---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-25-000427"
form_type: "8-K"
ticker: null
cik: "0001708331"
company_name: "Virpax Pharmaceuticals, Inc."
filed_at: "2025-03-21T23:59:59+00:00"
generated_at: "2026-05-24T08:47:17.527424+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Virpax Pharmaceuticals effects 1-for-25 reverse stock split effective March 21, 2025

## Summary
- Reverse split ratio set at 1-for-25, effective 12:01 a.m. ET on March 21, 2025.
- Outstanding shares reduced from 31,062,581 to 1,242,504.
- Trading symbol VRPX unchanged; new CUSIP 928251305.
- Board approved final ratio on March 5, 2025, following stockholder authorization on January 15, 2025.
- Equity awards and warrants proportionally adjusted for the split.

## SEC filing metadata
- accession: 0001731122-25-000427
- form_type: 8-K
- cik: 0001708331
- company_name: Virpax Pharmaceuticals, Inc.
- filed_at: 2025-03-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708331/000173112225000427/0001731122-25-000427-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708331/000173112225000427/e6439_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-25-000427
- JSON: https://secwatch.observer/filing/0001731122-25-000427.json
- Plain text: https://secwatch.observer/filing/0001731122-25-000427.txt

## Key facts
- Governance Changes
  Virpax Pharmaceuticals, Inc.: Filed a Certificate of Amendment to effect a 1-for-25 reverse stock split of common stock (effective 2025-03-21).
  - Change: charter amendment
  - Effective: 2025-03-21
  source text: On March 12, 2025, Virpax Pharmaceuticals, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware (the “Certificate of Amendment”) to effect a 1-for-25 reverse stock split
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708331/000173112225000427/0001731122-25-000427-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.